Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ARM vs MRNA✓SelectedUSD · MRNAARM vs MRNA performance historyLatest closeAs of-14.09%11/20
Stock and ETF performance explorer

ARM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+139.3%
MRNA return
+79.6%
Excess return
+59.8%
Maximum drawdown
-65.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-14.1%-2.2%-11.9%-13.9%
7D-20.1%-12.7%-7.4%-19.4%
30D-32.8%-20.7%-12.2%-31.8%
3M-39.3%+46.3%-85.6%-40.9%
6M-40.7%+305.2%-346.0%-51.7%
YTD+39.2%+561.2%-522.0%+0.3%
1Y+14.8%+772.1%-757.3%-23.0%
3Y+159.4%+147.0%+12.4%+101.9%
All+139.3%+79.6%+59.8%+95.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling